Dr. Marcus Noel, MD
Claim this profileMedStar Georgetown University Hospital
Studies Adenocarcinoma
Studies Pancreatic Cancer
8 reported clinical trials
18 drugs studied
Area of expertise
1Adenocarcinoma
Stage IV
Stage III
2Pancreatic Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Marcus Noel, MD is currently running
HN-STAR
for Head and Neck Cancer
People who have been treated for head and neck cancer (HNC survivors) can experience serious consequences from their cancer and its treatment, ongoing risks of new cancers, and other unrelated illnesses. These concerns pose challenges to the provision of comprehensive care to HNC survivors. We created HN-STAR to facilitate and tailor the ongoing care of HNC survivors. Survivors use HN-STAR on a computer or tablet to answer questions about symptoms and health concerns before a routine visit with a cancer care provider. During the clinic visit, the provider uses HN-STAR to see evidence-based recommendations for managing each concern reported by the survivor. The provider and survivor discuss recommendations and select appropriate actions (e.g., testing, referrals, prescriptions, self-management). HN-STAR produces a survivorship care plan that includes all reported concerns and the actions selected in clinic. The survivorship care plan is given to the survivor and the primary care provider. Three months, six months, and nine months later, the survivor uses HN-STAR from home (or clinic) to report their concerns again, and a new survivorship care plan is created each time. Our trial randomizes 20-36 oncology practices from the National Community Oncology Research Program to use HN-STAR or provide usual care to 298-400 recent survivors of head and neck cancer. We hypothesize that survivors in the HN-STAR arm will have greater improvement in patient-centered outcomes (including cancer-related well-being, symptoms, and patient activation) over one year compared to survivors in the usual care arm, measured by surveys at baseline and one year later. We also hypothesize that survivors in the HN-STAR arm will be more likely to receive care that is aligned with evidence-based recommendations during the year of the study than survivors in the usual care arm. Our final aim investigates the implementation of HN-STAR in clinical practice, using interviews and surveys of survivors, providers, and other clinic staff to understand the feasibility, acceptability, appropriateness, and other aspects of providing survivorship care to head and neck cancer survivors.
Recruiting1 award N/A7 criteria
Glufosfamide vs Fluorouracil
for Pancreatic Cancer
This trial is testing if the chemotherapy drug glufosfamide can help people with advanced pancreatic cancer live longer. These patients have already tried another treatment called gemcitabine, which didn't work for them. Glufosfamide aims to stop cancer cells from growing by damaging their DNA.
Recruiting3 awards Phase 39 criteria
More about Marcus Noel, MD
Clinical Trial Related3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Marcus Noel, MD has experience with
- Fluorouracil
- Eryaspase
- FOLFIRINOX
- Glufosfamide
- FOLFOX
- Tucatinib
Breakdown of trials Marcus Noel, MD has run
Adenocarcinoma
Pancreatic Cancer
Rectal Cancer
Cervical Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marcus Noel, MD specialize in?
Marcus Noel, MD focuses on Adenocarcinoma and Pancreatic Cancer. In particular, much of their work with Adenocarcinoma has involved Stage IV patients, or patients who are Stage III.
Is Marcus Noel, MD currently recruiting for clinical trials?
Yes, Marcus Noel, MD is currently recruiting for 3 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Marcus Noel, MD has studied deeply?
Yes, Marcus Noel, MD has studied treatments such as Fluorouracil, Eryaspase, FOLFIRINOX.
What is the best way to schedule an appointment with Marcus Noel, MD?
Apply for one of the trials that Marcus Noel, MD is conducting.
What is the office address of Marcus Noel, MD?
The office of Marcus Noel, MD is located at: MedStar Georgetown University Hospital, Washington, District of Columbia 20007 United States. This is the address for their practice at the MedStar Georgetown University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.